Zhaoke Ophthalmology Limited (HKG:6622)
1.720
-0.020 (-1.15%)
Apr 28, 2025, 4:08 PM HKT
Zhaoke Ophthalmology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | - | -385.04 | -407.32 | -2,130 | -726.98 | Upgrade
|
Depreciation & Amortization | - | 42.09 | 34.87 | 25.77 | 19.83 | Upgrade
|
Other Amortization | - | 6.62 | 0.21 | 0.06 | 0.02 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | - | - | 0.01 | Upgrade
|
Stock-Based Compensation | - | 22.02 | 46.68 | 109.86 | 15 | Upgrade
|
Other Operating Activities | - | -74.85 | -6.14 | 1,746 | 607.7 | Upgrade
|
Change in Accounts Receivable | - | 14.76 | -27.66 | -28.82 | -3.43 | Upgrade
|
Change in Accounts Payable | - | 54.41 | 35.14 | 5.23 | 26.56 | Upgrade
|
Change in Unearned Revenue | - | 0.74 | -0.04 | -0.04 | -0.04 | Upgrade
|
Change in Other Net Operating Assets | - | -4.42 | -6.79 | 26.55 | -42.09 | Upgrade
|
Operating Cash Flow | - | -323.66 | -331.05 | -245.14 | -103.43 | Upgrade
|
Capital Expenditures | - | -36.47 | -78.65 | -65.53 | -66.36 | Upgrade
|
Sale of Property, Plant & Equipment | - | 20.49 | 23.78 | - | - | Upgrade
|
Sale (Purchase) of Intangibles | - | -58.8 | -159.9 | -28.96 | -109.6 | Upgrade
|
Investment in Securities | - | 9.78 | - | 787.94 | -770.38 | Upgrade
|
Other Investing Activities | - | -10.78 | -109.8 | -9.93 | -9.15 | Upgrade
|
Investing Cash Flow | - | -75.77 | -324.57 | 683.52 | -955.48 | Upgrade
|
Short-Term Debt Issued | - | 120.82 | 93.81 | 0.69 | 10 | Upgrade
|
Total Debt Issued | - | 120.82 | 93.81 | 0.69 | 10 | Upgrade
|
Short-Term Debt Repaid | - | -8.74 | -9.6 | -0.4 | - | Upgrade
|
Long-Term Debt Repaid | - | -8.76 | -6.09 | -4.15 | -3.4 | Upgrade
|
Total Debt Repaid | - | -17.5 | -15.69 | -4.55 | -3.4 | Upgrade
|
Net Debt Issued (Repaid) | - | 103.32 | 78.12 | -3.86 | 6.6 | Upgrade
|
Issuance of Common Stock | - | 1.85 | 1.25 | 1,743 | - | Upgrade
|
Other Financing Activities | - | -5.88 | -3.14 | -80.96 | -30.92 | Upgrade
|
Financing Cash Flow | - | 99.29 | 76.23 | 1,659 | 973.69 | Upgrade
|
Foreign Exchange Rate Adjustments | - | 45.41 | 167.31 | -33.56 | -4.45 | Upgrade
|
Net Cash Flow | - | -254.73 | -412.08 | 2,063 | -89.67 | Upgrade
|
Free Cash Flow | - | -360.13 | -409.7 | -310.67 | -169.79 | Upgrade
|
Free Cash Flow Margin | - | -1920.70% | - | - | - | Upgrade
|
Free Cash Flow Per Share | - | -0.66 | -0.76 | -0.75 | -1.12 | Upgrade
|
Cash Interest Paid | - | 5.88 | 3.14 | 1.95 | 1.66 | Upgrade
|
Levered Free Cash Flow | - | -368.51 | -574.21 | -205.42 | -256.61 | Upgrade
|
Unlevered Free Cash Flow | - | -363.56 | -572.24 | -204.2 | -255.58 | Upgrade
|
Change in Net Working Capital | 120.58 | 55.45 | 157.74 | -3.89 | 41.38 | Upgrade
|
Updated Sep 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.